Suppr超能文献

人细胞毒性T细胞克隆对MHC I类同种异体抗原的肾细胞限制性识别。

Kidney cell-restricted recognition of MHC class I alloantigens by human cytolytic T cell clones.

作者信息

Hadley G A, Mohanakumar T

机构信息

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

Transplantation. 1993 Feb;55(2):400-4. doi: 10.1097/00007890-199302000-00031.

Abstract

The kidney expresses antigens not generally expressed by other cells in the body. To test the hypothesis that kidney-restricted antigens alter T cell recognition of MHC class I alloantigens, a panel of human T cell clones was established using an allogeneic kidney cell line (KCL) as the source of stimulator cells. Unexpectedly, a majority of these clones lysed the stimulating KCL in an allospecific manner but completely failed to lyse lymphoid cell targets derived from the KCL donor. Three of the KCL-reactive clones have been characterized in detail. All three are CD8+/CD4-, alpha/beta TCR,+ and their lytic activity is blocked by monoclonals to HLA class I framework determinants. Mapping studies using a panel of KCL targets, and blocking studies with allele-specific monoclonals indicated that clone 1-5 is directed to HLA-A3, clone 3-10 to HLA-B62 (putatively), and clone 5-2 to HLA-B51. Direct lysis and cold target inhibition assays demonstrated that clones 1-5 and 3-10 recognize their target class I alloantigens on KCL but not on EBV-transformed B cells or PHA-stimulated T cells. FACS analysis and HLA phenotyping excluded quantitative or qualitative deficiencies in HLA class I expression on the lymphoid cell targets as likely mechanisms of tissue specificity. These data suggest that kidney-restricted antigens may play a role in T cell recognition of MHC class I alloantigens, and they raise the possibility that parenchymal cell-restricted effector populations may contribute to rejection of renal allografts.

摘要

肾脏表达的抗原通常在体内其他细胞中不表达。为了验证肾脏限制性抗原改变T细胞对MHC I类同种异体抗原识别的假说,使用同种异体肾细胞系(KCL)作为刺激细胞来源建立了一组人T细胞克隆。出乎意料的是,这些克隆中的大多数以同种特异性方式裂解刺激的KCL,但完全不能裂解来自KCL供体的淋巴细胞靶标。已对三个KCL反应性克隆进行了详细表征。这三个克隆均为CD8 + / CD4-、α/βTCR +,并且它们的裂解活性被针对HLA I类框架决定簇的单克隆抗体阻断。使用一组KCL靶标的定位研究以及用等位基因特异性单克隆抗体进行的阻断研究表明,克隆1-5针对HLA-A3,克隆3-10(推测)针对HLA-B62,克隆5-2针对HLA-B51。直接裂解和冷靶抑制试验表明,克隆1-5和3-10在KCL上识别其靶标I类同种异体抗原,但在EBV转化的B细胞或PHA刺激的T细胞上则不能识别。FACS分析和HLA分型排除了淋巴细胞靶标上HLA I类表达的数量或质量缺陷作为组织特异性的可能机制。这些数据表明,肾脏限制性抗原可能在T细胞对MHC I类同种异体抗原的识别中起作用,并且它们增加了实质细胞限制性效应细胞群可能导致肾移植排斥反应的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验